サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：アルボウイルス検査の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 検査タイプ別、エンドユーザー別、地域別
市場調査レポート
商品コード
1394139

アルボウイルス検査の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 検査タイプ別、エンドユーザー別、地域別

Arbovirus Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日: | 発行: Fairfield Market Research | ページ情報: 英文 172 Pages | 納期: 2～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
アルボウイルス検査の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 検査タイプ別、エンドユーザー別、地域別
出版日: 2023年12月05日
発行: Fairfield Market Research
ページ情報: 英文 172 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界のアルボウイルス検査の市場規模は、2024年から2031年までの予測期間中に大幅な成長を遂げる見通しです。アルボウイルスは、主に蚊やマダニのような感染節足動物を介してヒトに感染し、公衆衛生への影響から注目が高まっています。

世界のアルボウイルス検査市場の成長は、アルボウイルスの急速な出現、公衆衛生上の課題の増加、政府の統合的イニシアチブの実施など、いくつかの要因にかかっています。これらの促進要因は、総体的に世界規模でのアルボウイルス検査市場の成長と拡大に寄与しています。

公衆衛生研究所は、世界中でアルボウイルス検査の最前線にいます。金額の面では、公衆衛生検査室セグメントは最大であり、評価期間を通じてこの地位を維持すると予想されます。その顕著な収益創出は、アルボウイルス検査市場全体の成長に大きく貢献しています。

エンドユーザーカテゴリの病院セグメントは、大幅な成長が見込まれ、金額ベースでトップセグメントの1つとなっています。成長率は比較的緩やかですが、アルボウイルス検査における病院の重要性の高まりを反映して、顕著な拡大が予測されています。

当レポートでは、世界のアルボウイルス検査市場について調査し、市場の概要とともに、検査タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界のアルボウイルス検査市場の見通し、2018年～2031年

  • 世界のアルボウイルス検査市場の見通し、検査タイプ別、金額（10億米ドル）、2018年～2031年
  • 世界のアルボウイルス検査市場の見通し、エンドユーザー別、金額（10億米ドル）、2018年～2031年
  • 世界のアルボウイルス検査市場の見通し、地域別、金額（10億米ドル）、2018年～2031年

第4章 北米のアルボウイルス検査市場の見通し、2018年～2031年

第5章 欧州のアルボウイルス検査市場の見通し、2018年～2031年

第6章 アジア太平洋のアルボウイルス検査市場の見通し、2018年～2031年

第7章 ラテンアメリカのアルボウイルス検査市場の見通し、2018年～2031年

第8章 中東・アフリカのアルボウイルス検査市場の見通し、2018年～2031年

第9章 競合情勢

  • メーカーとエンドユーザー別のヒートマップ
  • 企業の市場シェア分析、2023年
  • 競争力ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
    • Diamedix Corporation
    • NovaTec Immundiagnostica GmbH
    • Euroimmun AG
    • Focus Diagnostics (Member of DiaSorin Group)
    • Standard Diagnostics, Inc.
    • IBL International (A Member of the Tecan Group) Alere

第10章 付録

目次

The global market for arbovirus testing is poised for substantial growth over the forecast period from 2024 to 2031, according to a comprehensive market study. Arboviruses, which are primarily transmitted to humans through infected arthropods like mosquitoes and ticks, have gained increasing attention due to their public health impact. The research report delves into the latest trends, opportunities, drivers, and challenges influencing the market, offering valuable insights for industry stakeholders.

Expanding Horizons in Arbovirus Testing

The scope of this research encompasses a thorough analysis of end-user preferences, competitive dynamics, regional outlook, and various test types within arbovirus testing. Asia-Pacific and Middle East & Africa emerge as promising markets, driven by their substantial populations at risk of arbovirus infections and high arbovirus prevalence. Manufacturers are focused on advancing diagnostic techniques, extending their applicability beyond a few infections, thereby fueling market growth.

Key Drivers of Growth

The growth of the global arbovirus testing market hinges on several factors, including the rapid emergence of arboviruses, increasing public health challenges, and the implementation of integrated government initiatives. These drivers collectively contribute to the growth and expansion of the arbovirus testing market on a global scale.

Dominance of Public Health Laboratories

Public health laboratories have been at the forefront of arbovirus testing efforts worldwide. In terms of value, the public health laboratory segment is the largest and is expected to maintain this position throughout the assessment period. Its remarkable revenue generation significantly contributes to the overall growth of the arbovirus testing market.

Hospitals on the Rise

The hospital segment within the end-user category is anticipated to experience substantial growth, positioning itself as one of the top segments in terms of value. Despite a comparatively slower growth rate, it is projected to expand noticeably, reflecting the increasing importance of hospitals in arbovirus testing.

Market Segmentation

The market segmentation for the arbovirus testing industry includes test types, end users, and regions:

By Test Type:

  • 1. ELISA-Based Tests
  • 2. RT-PCR Based Tests

By End User:

  • 1. Hospitals
  • 2. Public Health Laboratories
  • 3. Diagnostic Centers
  • 4. Others

By Region:

  • 1. North America
  • 2. Latin America
  • 3. Europe
  • 4. Asia Pacific (APAC)
  • 5. Middle East and Africa (MEA)

The global arbovirus testing market is set to witness significant growth and innovation in the coming years, with a range of opportunities and challenges for businesses in this sector. Stakeholders, including manufacturers, healthcare providers, and public health agencies, are gearing up to address the growing threat of arbovirus infections and contribute to the advancement of diagnostic capabilities.

Table of Contents

1. Executive Summary

  • 1.1. Global Arbovirus Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Arbovirus Testing Market Outlook, 2018 - 2031

  • 3.1. Global Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. ELISA-Based Tests
      • 3.1.1.2. RT-PCR Based Tests
  • 3.2. Global Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Public Health Laboratory
      • 3.2.1.3. Diagnostic Centers
      • 3.2.1.4. Others
  • 3.3. Global Arbovirus Testing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Arbovirus Testing Market Outlook, 2018 - 2031

  • 4.1. North America Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. ELISA-Based Tests
      • 4.1.1.2. RT-PCR Based Tests
  • 4.2. North America Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals
      • 4.2.1.2. Public Health Laboratory
      • 4.2.1.3. Diagnostic Centers
      • 4.2.1.4. Others
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.2. U.S. Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 4.3.1.3. Canada Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.4. Canada Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Arbovirus Testing Market Outlook, 2018 - 2031

  • 5.1. Europe Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. ELISA-Based Tests
      • 5.1.1.2. RT-PCR Based Tests
  • 5.2. Europe Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals
      • 5.2.1.2. Public Health Laboratory
      • 5.2.1.3. Diagnostic Centers
      • 5.2.1.4. Others
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.2. Germany Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.3. U.K. Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.4. U.K. Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.5. France Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.6. France Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.7. Italy Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.8. Italy Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.9. Turkey Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.10. Turkey Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.11. Russia Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.12. Russia Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Arbovirus Testing Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. ELISA-Based Tests
      • 6.1.1.2. RT-PCR Based Tests
  • 6.2. Asia Pacific Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals
      • 6.2.1.2. Public Health Laboratory
      • 6.2.1.3. Diagnostic Centers
      • 6.2.1.4. Others
    • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.2. China Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.3. Japan Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.4. Japan Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.5. South Korea Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.6. South Korea Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.7. India Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.8. India Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Arbovirus Testing Market Outlook, 2018 - 2031

  • 7.1. Latin America Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. ELISA-Based Tests
      • 7.1.1.2. RT-PCR Based Tests
  • 7.2. Latin America Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Hospitals
      • 7.2.1.2. Public Health Laboratory
      • 7.2.1.3. Diagnostic Centers
      • 7.2.1.4. Others
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.2. Brazil Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.3. Mexico Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.4. Mexico Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.5. Argentina Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.6. Argentina Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Arbovirus Testing Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. ELISA-Based Tests
      • 8.1.1.2. RT-PCR Based Tests
  • 8.2. Middle East & Africa Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals
      • 8.2.1.2. Public Health Laboratory
      • 8.2.1.3. Diagnostic Centers
      • 8.2.1.4. Others
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.2. GCC Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.3. South Africa Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.4. South Africa Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.5. Egypt Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.6. Egypt Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.7. Nigeria Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.8. Nigeria Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs by End User Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Diamedix Corporation
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. NovaTec Immundiagnostica GmbH
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Euroimmun AG
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Focus Diagnostics (Member of DiaSorin Group)
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Standard Diagnostics, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. IBL International (A Member of the Tecan Group)
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Alere
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations